Eyebot develops an eye examination technology to eliminate barriers and provide quality vision care.
Eyebot has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.
Eyebot's investors include National Science Foundation, General Catalyst, Village Global, AlleyCorp, Baukunst.
Eyebot is headquartered in Boston, United States.
Eyebot develops an eye examination technology to eliminate barriers and provide quality vision care.
Eyebot is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eyebot — Funding & Investors." VCBacked, August 26, 2025, https://www.vcbacked.co/company/eyebot. Accessed September 2, 2026.
VCBacked. (2025). Eyebot — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/eyebot
{{cite web |title=Eyebot — Funding & Investors |url=https://www.vcbacked.co/company/eyebot |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated